Literature DB >> 19335208

Cathepsin B release from rodent intestine mucosa due to mechanical injury results in extracellular matrix damage in early post-traumatic phases.

Anna Vreemann1, Hong Qu, Kristina Mayer, Louise Bjorkholt Andersen, M Irina Stefana, Sven Wehner, Mariola Lysson, Anca M Farcas, Christoph Peters, Thomas Reinheckel, Jörg Kalff, Klaudia Brix.   

Abstract

An in vivo model was used to investigate the role of cathepsins in mouse intestine after mechanical manipulation. Inspection of different intestine segments by immunofluorescence microscopy provided evidence for a local release of cathepsin B from cells of individual gut sections shortly after traumatic injury. Densitometry of immunoblots ruled out alterations in cathepsin B expression levels. Because similar results were obtained with both mouse and rat intestine trauma models, we were interested in identifying potential targets of released cathepsin B in early post-traumatic phases. Immunoblotting revealed initial declines followed by an increase in protein levels of claudin-1 and E-cadherin, indicating that tight junctions and cell-cell adhesions were only transiently compromised by surgical trauma. Apical aminopeptidase N and dipeptidyl peptidase IV were only slightly affected, whereas basolateral low-density lipoprotein receptors were strongly up-regulated in response to trauma. As potential targets of cathepsin B released from injured cells, we identified collagen IV and laminin of the basement membrane that was damaged during initial post-traumatic stages. Because increased collagen IV expression was observed in the intestine of cathepsin B-deficient animals, we propose a direct role of cathepsin B in that it contributes to acute post-traumatic extracellular matrix damage and may thereby facilitate onset of post-operative ileus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335208     DOI: 10.1515/BC.2009.055

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  11 in total

1.  Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice.

Authors:  Fiore Cattaruzza; Victoria Lyo; Ella Jones; David Pham; James Hawkins; Kimberley Kirkwood; Eduardo Valdez-Morales; Charles Ibeakanma; Stephen J Vanner; Matthew Bogyo; Nigel W Bunnett
Journal:  Gastroenterology       Date:  2011-07-28       Impact factor: 22.682

Review 2.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

Review 3.  Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.

Authors:  Gregory Hook; Thomas Reinheckel; Junjun Ni; Zhou Wu; Mark Kindy; Christoph Peters; Vivian Hook
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

4.  Effects of cathepsin K deficiency on intercellular junction proteins, luminal mucus layers, and extracellular matrix constituents in the mouse colon.

Authors:  Maria Arampatzidou; André Schütte; Gunnar C Hansson; Paul Saftig; Klaudia Brix
Journal:  Biol Chem       Date:  2012-12       Impact factor: 3.915

Review 5.  Soluble E-cadherin: more than a symptom of disease.

Authors:  Magdalena M Grabowska; Mark L Day
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

6.  Cathepsin B trafficking in thyroid carcinoma cells.

Authors:  Sofia Tedelind; Silvia Jordans; Henrike Resemann; Galia Blum; Matthew Bogyo; Dagmar Führer; Klaudia Brix
Journal:  Thyroid Res       Date:  2011-08-03

Review 7.  Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders.

Authors:  Vivian Hook; Michael Yoon; Charles Mosier; Gen Ito; Sonia Podvin; Brian P Head; Robert Rissman; Anthony J O'Donoghue; Gregory Hook
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-04-17       Impact factor: 3.036

Review 8.  Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.

Authors:  Gregory Hook; J Steven Jacobsen; Kenneth Grabstein; Mark Kindy; Vivian Hook
Journal:  Front Neurol       Date:  2015-09-02       Impact factor: 4.003

9.  Cathepsin B is up-regulated and mediates extracellular matrix degradation in trabecular meshwork cells following phagocytic challenge.

Authors:  Kristine Porter; Yizhi Lin; Paloma B Liton
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

Review 10.  Claudins in intestines: Distribution and functional significance in health and diseases.

Authors:  Zhe Lu; Lei Ding; Qun Lu; Yan-Hua Chen
Journal:  Tissue Barriers       Date:  2013-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.